Merck edges higher to $125.22 as company unveils new Phase 3 HIV data with Gilead partnership

Traders Union
All News
Companies
Merck rises 0.66% today

Highlights

MRK maintains a robust bullish technical structure, trading above key short-, medium-, and long-term moving averages despite a recent pullback.
Momentum indicators signal mixed near-term sentiment, with MACD and Awesome Oscillator bullish, but oscillators diverge and Stoch RSI signals potential loss of upward momentum.
For the coming week, MRK is projected to trade between $122.50 and $128.70, with high probability of continued consolidation or renewed upside if resistance breaks.

Bullish structure confirmed as price holds above key support levels

MRK is trading just above its MA-20 ($125.08), well above the MA-50 ($119.76) and MA-200 ($109.70), confirming a strongly bullish structure across short, medium, and long-term horizons. The Ichimoku Kijun sits at $121.65, acting as immediate support just below the current price. Near-term support is identified at the Ichimoku Kijun level ($121.65), with key support from the MA-50 ($119.76). Resistance is seen near the MA-20 ($125.08), while the next key resistance is at the cluster of MA-100 ($118.34) and MA-200 ($109.70), but both are distant and less relevant for the current trading range.

Diverging momentum signals amid buyer strength and recent pullback

Momentum on D1 is mixed, with MACD giving a strong buy signal, while ADX remains neutral at low levels, indicating weak trend strength. RSI is mid-range and bullish, CCI is neutral, while Stoch RSI signals sell, pointing to mild loss of upward momentum. BBP is firmly in overbought territory (2.72), highlighting prevailing buyer strength, though oscillators are diverging and do not present a unified momentum picture. The Awesome Oscillator is supporting continued upside pressure. Over the past week, MRK has fallen $2.31 (1.81%) from a previous close of $127.53, now trading in the lower part of its weekly range. Weekly volatility stands at a notable 7.31%, with the tone showing a steady pullback from a recent high.

Strong bullish bias persists as volatility shapes trading corridor

Looking ahead to the next week, MRK is expected to fluctuate between $122.50 and $128.70, reflecting recent volatility and staying well within the bounds of the 52-week range ($76.66–$131.72). The probability of a further price increase is very high (more than 80%), supported by bullish signals from W1 MA-50, RSI-W1, ADX-W1, and MACD-W1, while the chance of a decline is low. The baseline scenario is continued sideways movement within the corridor. The bullish scenario could see MRK retest or breach the upper band above $128.70 if near-term resistance is overcome. Conversely, a bearish scenario may unfold if support at $121.65 is lost, potentially driving prices toward the low $120s.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

In a recent review, analysts highlighted Merck's strong bullish momentum supported by robust technical signals. With ongoing developments, investors should closely monitor for any shifts in trend or volatility, as the prevailing scenario suggests further opportunities may emerge.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.